Biopharma Capital Limited is an adviser based in Paris. It manages $3 million of regulatory assets for 1 client accounts. It has been registered with the SEC as an adviser since 2002.
Biopharma Capital Limited provides portfolio management for investment companies and portfolio management for pooled investment vehicles. It doesn't provide financial planning services to its clients. On top of advisory services, the firm doesn't engage in other business activities.
The assets under management (AUM) of Biopharma Capital Limited is $3 million, all of which is managed in discretionary accounts. The firm's AUM has gone down by -75% since the beginning of its operation, and the company doesn't manage any assets belonging to foreign clients.
The advisory firm has several streams of revenue. Clients pay Biopharma Capital Limited for their services and products based on a percentage of assets under management and performance-based fees. The adviser charges an additional fee when a set benchmark is outperformed. These fees don’t include brokerage commissions, interest, taxes, and other account expenses.
Libbe Lipkin Englander has been acting as President since 1 Mar 2000. It Asset Management S.A. joined the executive team most recently as the Shareholder.
The principal office where Biopharma Capital Limited performs its advisory services is located at C/O It Asset Management, Paris, 75008, which is also the mailing address of the firm. The firm also has an office outside of the United States.
You can reach the main office by calling the phone number (011)(33) 1 70 75 10 70 or by fax (O11)(33) 1 70 75 10 75. The normal business hours are 9:00 a.m. - 7:00 p.m. on Monday - Friday.